RO 3306

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 1530

CAS [872573-93-8]

MF C18H13N3OS2
MW 351.45

Purity: 99%
Soluble in DMSO

RO 3306

Description

Selective CDK 1 inhibitor (Ki = 35 nM and 110 nM for Cdk1/B1 and Cdk1/A, respectively), which induces cell cycle arrest and actively enhances downstream p53 signaling to promote apoptosis in AML cell lines.

LT Vassilev et al. Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1. Proc Natl Acad Sci USA. 2006, 103(28), 10660–10665.

K Kojima et al. The CDK1 inhibitor RO-3306 enhances p53-mediated Bax activation and mitochondrial apoptosis in AML. Cancer Sci. 2009, 100(6), 1128–1136.

List of publications using RO 3306 (Axon 1530) purchased from Axon Medchem

CDK1 inhibitor

Chemical name

5-(Quinolin-6-ylmethylene)-2-(thiophen-2-ylmethylamino)thiazol-4(5H)-one

Parent CAS No.

[872573-93-8]

Order

Size	Unit Price	Stock
5 mg	€80.00	In Stock
25 mg	€260.00	In Stock

Special Offers

Size	Unit Price	Stock
2 x 5 mg	€120.00	In Stock
2 x 25 mg	€400.00	In Stock

Need more? Bulk Inquiry

Related Products

Axon ID	Name	Description	From price
3228	CDK inhibitor CR8	Potent CDK inhibitor (1, 2, 5, 7, and 9 specific)		€130.00
3402	THZ531	First-in-class, potent, selective, covalent CDK12/CDK13 inhibitor		€130.00

Customer Support

Customer Services

About Axon Medchem

Contact Us

RO 3306

Description

Chemical name

Parent CAS No.

Customer Support

About Axon Medchem

Download Product Catalog

Follow Us

Customer Support

Customer Services

About Axon Medchem

Contact Us

RO 3306

Description

Chemical name

Parent CAS No.

Related Products

Customer Support

About Axon Medchem

Download Product Catalog

Follow Us

Send us a message

Contact Us